Table 2.
Osteopenia | Osteoporosis | Established | |
Raloxifene | ● | ■ | ■ |
Alendronate | NA | ■ | ■ |
Risedronate | NA | ● | ■ |
Ibandronate | NA | ■ | ■ |
Zoledronate | NA | ■ | ■ |
Teriparatide | NA | NA | ■ |
Strontium ranelate | ● | ■ | ■ |
Denosumab | NA | ■ | ■ |
■ Denotes a preplanned analysis in the entire study population; ●Denotes a post hoc analysis. NA: No evidence available. Adapted from: Body et al[12].